Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Vascular Access Devices Market is Expected to Surge at a Significant CAGR of 6.64% and is also Contemplated to Reach Upto USD 6.13 Billion by 2026, Estimates DelveInsight

The Vascular Access Device market is anticipated to grow tremendously in the coming years due to many factors which include the rising prevalence of end-stage renal diseases and the rising number of vascular access surgeries, these are striving the Vascular Access Devices demand, thus driving the growth of Vascular Access Device market.

Las Vegas, USA, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Vascular Access Devices Market is Expected to Surge at a Significant CAGR of 6.64% and is also Contemplated to Reach Upto USD 6.13 Billion by 2026, Estimates DelveInsight

The Vascular Access Device market is anticipated to grow tremendously in the coming years due to many factors which include the rising prevalence of end-stage renal diseases and the rising number of vascular access surgeries, these are striving the Vascular Access Devices demand, thus driving the growth of Vascular Access Device market.

DelveInsight's Vascular Access Devices Market Insights and Forecast report provides the current and forecast Vascular Access Devices, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Vascular Access Devices.

Some of the essential takeaways from the Vascular Access Devices Market report:

  • According to DelveInsight analysis, North America is expected to dominate the overall Vascular Access Devices Market during the forecast period.

  • Key pharma players proactively working in the Vascular Access Devices market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

  • As per DelveInsight estimates, Global Vascular Access Devices was valued at USD 4.31 billion in 2020 and is anticipated to grow at a tremendous CAGR of 6.64% during the forecast period from 2021 to 2026 and is also expected to reach USD 6.13 billion by 2026.

  • On June 02, 2021, medK had launched a needle-free solution for vascular access. The needle-free connection tends to offer access to the fluid lines, thereby reducing the risk of needle sticks.

  • On October 01, 2020, Medtronic had acquired the medical device company Avenu Medical. The company Avenu Medical is focusing on the construction of minimally invasive endovascular arteriovenous fistulae for the treatment of end-stage renal disease patients undergoing dialysis.